| Min Pa: | Min Pa(max): | Activity's type: |
| Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |
|---|---|---|---|---|---|---|
| 0.986 | 0.001 | 0.986 | Gastric antisecretory | 0.925 0.001 DBMET01169 | ||
| 0.908 | 0.001 | 0.908 | Antibacterial (Helicobacter pylori) | 0.564 0.003 DBMET01169 | ||
| 0.88 | 0.001 | 0.88 | Potassium channel (ATP-sensitive) blocker | 0.318 0.003 DBMET01169 | ||
| 0.866 | 0.001 | 0.994 | H+/K+-transporting ATPase inhibitor | 0.994 0 DBMET01169 | DBMET01169 | |
| 0.631 | 0.005 | 0.631 | Potassium channel blocker | 0.524 0.009 DBMET01169 | ||
| 0.594 | 0.002 | 0.594 | Gastrin inhibitor | |||
| 0.521 | 0.022 | 0.521 | Histamine release inhibitor | |||
| 0.445 | 0.003 | 0.445 | ATPase inhibitor | |||
| 0.399 | 0.002 | 0.399 | Potassium channel (Inward rectifier) blocker | 0.161 0.004 DBMET01169 | ||
| 0.392 | 0.006 | 0.392 | Interleukin 1 antagonist | |||
| 0.366 | 0.003 | 0.366 | Histamine H2 receptor antagonist | |||
| 0.347 | 0.004 | 0.347 | ABCA1 expression enhancer | |||
| 0.285 | 0.01 | 0.285 | Interleukin 1b antagonist | |||
| 0.301 | 0.036 | 0.301 | Platelet aggregation inhibitor | |||
| 0.272 | 0.054 | 0.272 | Interleukin antagonist | |||
| 0.292 | 0.1 | 0.292 | Calcium channel activator | |||
| 0.305 | 0.131 | 0.305 | Antibacterial | |||
| 0.252 | 0.09 | 0.252 | Spasmolytic | |||
| 0.192 | 0.038 | 0.192 | Bone formation stimulant | |||
| 0.249 | 0.102 | 0.249 | Ca(v)3.3 blocker | |||
| 0.174 | 0.031 | 0.174 | MAP kinase 12 inhibitor | |||
| 0.191 | 0.07 | 0.191 | P-glycoprotein inhibitor | |||
| 0.124 | 0.021 | 0.124 | Phosphodiesterase 6D inhibitor | |||
| 0.14 | 0.044 | 0.14 | Alpha 2b adrenoreceptor antagonist | |||
| 0.129 | 0.048 | 0.129 | MAP kinase 13 inhibitor | |||
| 0.093 | 0.013 | 0.093 | Fatty acid synthase inhibitor | |||
| 0.093 | 0.025 | 0.093 | Phosphodiesterase VI inhibitor | |||
| 0.075 | 0.009 | 0.075 | Histamine H2 receptor agonist | |||
| 0.165 | 0.1 | 0.189 | MAP kinase kinase 5 inhibitor | 0.189 0.046 DBMET01169 | DBMET01169 | |
| 0.096 | 0.035 | 0.096 | Na+ K+ transporting ATPase inhibitor | |||
| 0.09 | 0.033 | 0.09 | Viral attachment inhibitor | |||
| 0.175 | 0.126 | 0.175 | Vasodilator | |||
| 0.115 | 0.067 | 0.115 | Platelet activating factor antagonist | |||
| 0.061 | 0.028 | 0.061 | Myc inhibitor | |||
| 0.059 | 0.033 | 0.059 | Acetyl-CoA transferase 2 inhibitor | |||
| 0.076 | 0.051 | 0.076 | MAP kinase 11 inhibitor | |||
| 0.067 | 0.043 | 0.067 | Leukotriene antagonist | |||
| 0.168 | 0.15 | 0.168 | Hypoglycemic | |||
| 0.07 | 0.052 | 0.07 | Calcium channel L-type blocker | |||
| 0.085 | 0.071 | 0.085 | Thioredoxin inhibitor | |||
| 0.042 | 0.028 | 0.042 | Acetyl-CoA transferase 1 inhibitor | |||
| 0.03 | 0.018 | 0.03 | Leukotriene B4 receptor 1 antagonist | |||
| 0.05 | 0.04 | 0.05 | Histamine agonist | |||
| 0.05 | 0.042 | 0.05 | Acetyl-CoA transferase inhibitor | |||
| 0.082 | 0.075 | 0.082 | Antihistaminic | |||
| 0.036 | 0.121 | 0.059 | Alpha 1L adrenoreceptor antagonist | 0.059 0.023 DBMET01169 | DBMET01169 | |
| 0.029 | 0.346 | 0.174 | Glutathione S-transferase inhibitor | 0.174 0.008 DBMET01169 | DBMET01169 | Ext | Pa | Pi | Pmax | Activity | Other Results | ID Pa_max |